Overall, this data indicates that, as an upstream modulator of LC3 and CD133, which are involved in tumor aggressiveness, TIPRL is a critical player in HCC/liver cancer cell proliferation, viability and stemness, which are key events for HCC incidence and progression. Here, PROM1 is linked to liver cancer.